Randomized Controlled Clinical Trial To Study Efficacy Of Hinstradi Kwath With Patoladi Kwath In The Management Of Urdhwag Amlapitta
Trial Snapshot
- Phase
- Phase 3 4
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Assessment will be done based on subjective criteria.
Study Overview
Brief Summary
Topic:-"RANDOMIZED CONTROLLED CLINICAL TRIAL TO STUDY EFFICACY OF HINSTRADI KWATH WITH PATOLADI KWATH IN THE MANAGEMENT OF URDHWAG AMLAPITTA"
Objectives
Primary Objectives:-To evaluate the efficacy of Hinstradi Kwath in the management of Urdhwag Amlapitta.
Secondary Objectives:-1.To compare the effect of Hinstradi Kwath and Patoladi Kwath in the management of Urdhwag Amlapitta.
Methodology :- Study design
Screening of patients for inclusion
Selection of patients on basis of Inclusion Criteria and Exclusion Criteria.
Consent taken Grouping of Patients
Trial will be conducted in our institute. Total 60 patients diagnosed with classical signs and symptoms of Urdhwag Amlapitta be selected and then will be divided in two groups.
Hinstradi Kwath will be given to one group and Patoladi Kwath will be given to another one.
The study will be conducted for 21 days. Result will be compared in two groups.
Data analysis will be done by using appropriate statistical test.
INCLUSION CRITERIA
1.Patients with clinical signs and symptoms of Urdhwag Amlapitta will be selected.
-
Patients of age group between 20-50 years.
-
Patients will be selected irrespective of age, Sex, socio economic status.
Exclusion Criteria:-
1.Those patients who are not willing to give consent.
- Patient will be excluded below age 20 years and above 50 years old.
3Patient suffering from any infectious disease like bacterial or viral.
4.Pregnant and lactating women.
Withdrawal Criteria :-
-
Patients who refuse to treatment.
-
Patients with irregular follow up.
3.If any complication or adverse effect found during period of treatment.
4.If symptoms aggravated during treatment will be withdrawn.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Masking
- Participant and Investigator Blinded
Eligibility Criteria
- Ages
- 20.00 Year(s) to 50.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •1.Patients with clinical signs and symptoms of Urdhwag Amlapitta will be selected.
- •Patients of age group between 20-50 years.
- •Patients will be selected irrespective of age, Sex, socio economic status.
Exclusion Criteria
- •1.Those patients who are not willing to give consent.
- •Patient will be excluded below age 20 years and above 50 years old.
- •3 Patient suffering from any infectious disease like bacterial or viral.
- •Pregnant and lactating women.
Outcomes
Primary Outcomes
Assessment will be done based on subjective criteria.
Time Frame: After 21 days
Subjective criteria is Avipak,Utklesha,Tikta Amla Udgara, Aruchi,Shirorujah,Gaurav
Time Frame: After 21 days
will be assessed based on before and after treatment.
Time Frame: After 21 days
Secondary Outcomes
No secondary outcomes reported
Investigators
Vd Shejal Bhujangrao Inkar
Vidarbha Ayurved Mahavidyalaya, Amravati